Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96072753 | 9607275 | 3 | F | 20160725 | 20131009 | 20160725 | EXP | ZA-BRISTOL-MYERS SQUIBB COMPANY-19532936 | BRISTOL MYERS SQUIBB | BARNARDT P, ET AL.. MANAGING AIDS-RELATED KAPOSI^S SARCOMA AND PREGNANCY. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE. 2013;14(2):87-8 | 24.00 | YR | F | Y | 1.38000 | KG | 20160725 | OT | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96072753 | 9607275 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | UNK | U | 20972 | CAPSULE, HARD | ||||||||
| 96072753 | 9607275 | 2 | SS | BLEOMYCIN SULFATE | BLEOMYCIN SULFATE | 1 | Unknown | UNK | Y | 0 | POWDER FOR SOLUTION FOR INJECTION | ||||||||
| 96072753 | 9607275 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK | Y | 0 | |||||||||
| 96072753 | 9607275 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 96072753 | 9607275 | 5 | SS | TENOFOVIR | TENOFOVIR | 1 | Unknown | UNK | U | 0 | |||||||||
| 96072753 | 9607275 | 6 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 96072753 | 9607275 | 7 | SS | TRIMETHOPRIM + SULFAMETHOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96072753 | 9607275 | 1 | HIV infection |
| 96072753 | 9607275 | 2 | HIV infection |
| 96072753 | 9607275 | 3 | Kaposi's sarcoma |
| 96072753 | 9607275 | 4 | Kaposi's sarcoma |
| 96072753 | 9607275 | 5 | HIV infection |
| 96072753 | 9607275 | 6 | HIV infection |
| 96072753 | 9607275 | 7 | Antifungal prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96072753 | 9607275 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96072753 | 9607275 | Maternal exposure during pregnancy | |
| 96072753 | 9607275 | Stillbirth |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96072753 | 9607275 | 1 | 2012 | 0 | ||
| 96072753 | 9607275 | 5 | 2012 | 0 | ||
| 96072753 | 9607275 | 6 | 2012 | 0 | ||
| 96072753 | 9607275 | 7 | 2012 | 0 |